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Optical coherence tomography (OCT) is a high-resolution imaging technique that oﬀers microscopic visualization of coronary
plaques.TheclearanddetailedimagesofOCTgenerateanintenseinterestinadoptingthistechniqueforbothclinicalandresearch
purposes. Recent studies have shown that OCT is useful for the assessment of coronary atherosclerotic plaques, in particular
the assessment of plaque rupture, erosion, and intracoronary thrombus in patients with acute coronary syndrome. In addition,
OCT may enable identifying thin-cap ﬁbroatheroma, the proliferation of vasa vasorum, and the distribution of macrophages
surrounding vulnerable plaques. With its ability to view atherosclerotic lesions in vivo with such high resolution, OCT provides
cardiologistswiththetooltheyneedtobetterunderstandthethrombosis-pronevulnerableplaquesandacutecoronarysyndromes.
This paper reviews the possibility of OCT for identiﬁcation of vulnerable plaques in vivo.
1.Introduction
Optical coherence tomography (OCT) is a recently devel-
oped intravascular imaging modality using near-infrared
light to create images [1–3]. The greatest advantage of OCT
is its high resolution (10 to 20μm), which is 10 times
higher than that of intravascular ultrasound (IVUS). OCT
can discriminate three layers of the coronary artery wall
demonstrating the intima as the signal rich layer nearest
the lumen, the media as the signal poor middle layer,
and the adventitia as the signal rich layer surrounding the
signal poor layer of the media [4]. With regard to tissue
characterization, OCT allows us to identify three types of
coronary plaques, such as ﬁbrous, ﬁbrocalciﬁc, and lipid.
Fibrous plaque is characterized by signal rich, homogenous
lesion, ﬁbrocalciﬁc plaque by signal poor, sharp border
lesion, and lipid rich plaques as signal poor, diﬀuse border
lesion [5]. A histology-controlled OCT study showed good
intra-andinterobserverreliabilities(κ = 0.83-0.84)andhigh
sensitivity and speciﬁcity in each plaque demonstrating 71–
79% and 97-98% for ﬁbrous plaques, 95-96% and 97% for
ﬁbrocalciﬁc plaques, and 90–94% and 90–92% for lipid-rich
plaques, respectively [5, 6]. Furthermore, OCT can detect
plaque rupture (Figure 1), erosion (Figure 2), intracoro-
nary thrombus (Figure 3), thin-cap ﬁbroatheroma (TCFA;
Figure 4), and calciﬁed nodule (Figure 5)[ 7–9]. Although
there are some limitations including shallow penetration
depth of the infra-red light and complex procedure of
image acquisition, the high resolution of OCT provides
more detailed structural information of the coronary artery
wall compared with conventional imaging modalities [10,
11]. Thus, OCT has been applied for the assessment of
culprit lesion morphologies in patients with acute coronary
syndrome (ACS).
2.Pathology of CulpritLesionsinACS
Autopsy studies have demonstrated that ACS results from
sudden luminal narrowing caused by thrombosis based on
plaque rupture, erosion, and superﬁcial calciﬁed nodule
[12, 13]. In these coronary features, plaque rupture is
the most frequent (55 to 60%), plaque erosion to be the
second (30 to 35%), and superﬁcial calciﬁed nodule to
be the least (2 to 7%) [12]. Plaque rupture is identiﬁed
by a presence of ﬁbrous cap discontinuity and a cavity
formation within the plaque. Atheroma with thin-ﬁbrous2 Cardiology Research and Practice
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Figure 1: Plaque rupture. Plaque rupture is deﬁned as a presence
of ﬁbrous-cap discontinuity (arrows) and a cavity formation (∗)i n
the plaque. Ruptured plaques usually have an extensive lipid core
and a thin ﬁbrous cap. The ﬁbrous cap is the thinnest at the site
of rupture, and the plaque cavity indicates loss of lipid core due to
rupture.
Figure 2:Plaqueerosion.Erosion(arrowhead)isusuallycomprised
of OCT evidence of thrombi (arrows), an irregular luminal surface,
and no evidence of cap rupture evaluated in multiple adjacent
frames. The characteristic of OCT features of erosions are a thick
intima and a small or absent lipid core. If the lipid core is present, it
does not communicate with luminal thrombi.
cap of <65μm is thought to be precursor lesion of plaque
rupture. Erosion has an area lacking surface endothelium
and occurs over lesion with thick intima. Calciﬁed nodule
is a plaque with luminal thrombi showing calciﬁc nodule
protruding into the lumen through a disrupted thin ﬁbrous
cap. Based on these pathohistological ﬁndings, thrombosis-
prone vulnerable plaques are characterized by 5 major and
5 minor features as listed in Table 1 [13]. Compared with
conventional imaging modalities, OCT has an ability to
identify these features more precisely in vivo.
Figure 3: Intracoronary thrombus. Thrombus is deﬁned as a
protrusion inside the lumen of the artery with signal attenuation.
White thrombus which consists mainly of platelets is identiﬁed as
signalrich,low-backscatteringprotrusionsintheOCTimage,while
red thrombus which consists mainly of red blood cells is identiﬁed
as high-backscattering protrusions inside the lumen of the artery,
with signal-free shadowing in the OCT image.
∗
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Figure 4: Thin-cap ﬁbroatheroma (TCFA). A ﬁbrous cap (arrows)
is identiﬁed as a signal-rich homogenous region overlying a lipid
core (∗), which is characterized by a signal-poor region. TCFA is
deﬁned as a plaque with a ﬁbrous cap measuring <65μm. OCT-
detected TCFAs are often observed in the culprit lesions of acute
coronary syndrome.
3. OCT Assessment of CulpritLesions inACS
The ﬁrst OCT study to assess in vivo culprit lesion morphol-
ogy in patients with ACS was conducted by Jang et al. [14].
They used a 3.2Fr. proto-type OCT catheter and revealed
higher frequency of TCFA in ACS compared with stable
angina pectoris (SAP) (72% in acute myocardial infarction
(AMI), 50% in unstable angina pectoris (UAP), and 20%
in SAP; P = 0.012). However, this study showed lower
frequency of thrombus and plaque rupture in AMI inCardiology Research and Practice 3
Figure 5: Calciﬁed nodule. Calciﬁed nodule is deﬁned as a pro-
trusion of a signal-poor or heterogeneous region with a sharply
delineated border. The origin of this lesion is not precisely known,
but it appears to be associated with healed plaques.
Table 1: Criteria for deﬁning vulnerable plaques [13].
Major criteria
(1)Activeinﬂammation(monocyte/macrophageandsometimes
T-cell inﬁltration)
(2) Thin cap with large lipid core
(3) Endothelial denudation with superﬁcial platelet aggregation
(4) Fissured plaque
(5) Stenosis > 90%
Minor criteria
(1) Superﬁcial calciﬁed nodule
(2) Glistening yellow
(3) Intraplaque hemorrhage
(4) Endothelial dysfunction
(5) Outward (positive) remodeling
comparison with previous pathological reports [12, 13]. The
thick OCT catheter, the time delay between the symptom
onset and imaging (4.6 ± 5.3 days), and the thrombolysis
and/or antiplatelet therapy before the imaging might aﬀect
the results. Thereafter, Kubo et al. [10] used commercially
available OCT system with a 0.014 inch optic ﬁber, IVUS,
and angioscopy in AMI within 6 hours from symptom onset.
This study showed superiorities of OCT for the detection
of plaque rupture (73% versus 40% versus 43%, P =
0.021), erosion (23% versus 0% versus 3%, P = 0.003),
and thrombus (100% versus 33% versus 100%, P<0.001)
compared with IVUS and angioscopy. The frequency of
OCT-detected plaque rupture, erosion, and thrombus was
similar to that of the pathological reports. The frequency of
OCT-detected TCFA was 83%, and the thickness of ﬁbrous
cap was 49 ± 21μm in AMI. Tanaka et al. [15]u s e dO C T
to compare the ruptured ﬁbrous cap thickness and the
rupture site between exertion-triggered and rest-onset ACS.
In the results, rest-onset ACS had thinner ruptured ﬁbrous-
cap thickness (50μmv e r s u s9 0 μm, P<0.010) and more
frequentruptureneartheshoulderoftheplaque(57%versus
93%, P = 0.014) in comparison with exertion-triggered
ACS. Interestingly, not only TCFAs but also thick cap (up to
150μm) ﬁbroatheromas were ruptured in exertion-triggered
ACS, and the high-sensitive C-reactive protein level was
negatively correlated with the thickness of the ruptured
ﬁbrous-cap. Exercise-induced high shear stress at the site of
the plaque shoulder and ﬁbrous-cap inﬂammation might be
associated with the ﬁbrous-cap disruption of >65μm thick.
By using OCT, Ino et al. [16] showed diﬀerences of ruptured
plaque morphologies between ST-segment elevated AMI
and non-ST-segment elevated ACS. Although the minimum
lumen area was similar in both groups, the ruptured cavity
size was signiﬁcantly larger in ST-segment elevated AMI
comparedwithnon-ST-segmentelevatedACS.Furthermore,
the ruptured plaque of which aperture was open wide
against the direction of coronary ﬂow was more often
seen in ST-segment elevated AMI compared with non-ST-
segment elevated ACS (46% versus 17%, P = 0.036). The
morphological feature of plaque rupture could relate to the
clinical presentation in patients with ACS. Mizukoshi et al.
[17] reported that the frequency of plaque rupture (43%
versus 13% versus 71%, P<0.001) and plaque erosion
(32% versus 7% versus 8%, P = 0.003) was signiﬁcantly
diﬀerent among the types of UAP; Braunwald class I, II, and
III. The ﬁbrous cap thickness (140μm versus 150μmv e r s u s
60μm, P<0.001), minimal lumen area (0.70mm2 versus
1.80mm2 versus 2.31mm2, P<0.001), and the frequency of
thrombus(72%versus30%versus73%,P<0.001)werealso
diﬀerent among the types of UAP. This clinical OCT study
disclosed that the culprit plaque in class III UAP might be
more vulnerable than the other classes.
Unstable lesion morphologies before percutaneous coro-
nary intervention (PCI) aﬀect the outcome after the pro-
cedure. An observational OCT study [18] demonstrated
that TCFA was often seen at target lesions of the patients
with noreﬂow after PCI compared with good reﬂow (50%
versus 16%, P = 0.005). The frequency of the noreﬂow
phenomenon increased according to the size of the lipid arc
as determined by OCT. A serial OCT study [19] showed
markedly diﬀerent vascular response up to 9 months after
drug-eluting stent implantation between the patients with
UAP and SAP. Acute stent malapposition (67% versus 32%,
P = 0.038) and tissue protrusion after PCI (79% versus
42%, P = 0.005) were observed more frequently in the
UAP patients. Plaque rupture was signiﬁcantly increased
after PCI in the UAP patients (42% to 75%, P = 0.018),
and the persistence of core cavity after plaque rupture at 9-
month’ followup (28% versus 4%, P = 0.031) was observed
more frequently in the UAP patients compared with the
SAP patients. At 9 months’ follow-up, the frequency of
malapposed stent (33% versus 4%, P = 0.012) and partially
uncovered stent by neointima (72% versus 37%, P = 0.019)
was signiﬁcantly greater in the UAP patients than that in the
SAP patients.
Recent OCT studies have suggested the development of
in-stent neoatherosclerosis after PCI. Kashiwagi et al. [20]4 Cardiology Research and Practice
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Figure 6: Neointimal plaque rupture. A 71-year-old male was
admitted to our hospital with very late (>10 years) bare-metal
stent thrombosis. OCT disclosed a plaque rupture (arrowhead) and
cavity formation (∗) within neointima in the stented segment
(arrows).
and Nishiguchi et al. [21] investigated the lesions with
very late stent thrombosis by using OCT and demonstrated
lipidic plaque formation, TCFA, and plaque rupture within
the neointima in the stented segments. Although late stent
thrombosisisthoughttobeassociatedwithdelayedendothe-
lialization, these reports highlight that it can occur despite
full stent coverage. Atherosclerotic developments within the
neointima might play an important role in very late stent
thrombosis (Figure 6).
4. OCT-Detected Vulnerable Plaques
Theterm“vulnerableplaque”isusedtodescribethrombosis-
prone plaques. The precursor lesion for plaque rupture
is characterized by a thin ﬁbrous cap heavily inﬁltrated
macrophages and an underlying lipid core. Virmani et al.
[12] deﬁned plaque vulnerability based on the actual
thickness of the histological section from measurements
made of plaque ruptures. TCFA was deﬁned as a lesion
with a ﬁbrous cap <65μm thick. A thickness of 65μm
was chosen as a criterion of instability because in rupture
the mean cap thickness was 23 ± 19μm; 95% of caps
measured less than 65μm within a limit of only two standard
deviations. At present, OCT might be the best tool to detect
TCFA in vivo [22–25]. Kume et al. [7] examined 35 lipid-
rich plaques from 38 human cadavers and demonstrated
a good correlation of the ﬁbrous cap thickness between
OCT and histology (r = 0.90; P<0.001). In the clinical
setting, Fujii et al. [26] showed that OCT-detected TCFA
was associated with high-sensitive C-reactive protein, and
its distribution in the coronary artery tree was similar to
that in the previous autopsy reports. Kashiwagi et al. [27]
usedmultidetectorcomputedtomographytocomparelesion
characteristics between OCT-detected TCFA and non-TCFA.
Positive remodeling (76% versus 31%, P<0.001) and ring-
like enhancement (44% versus 4%, P<0.001) as determined
bymultidetectorcomputedtomographywereobservedmore
frequently in OCT-detected TCFAs than in non-TCFAs.
Computed tomography attenuation value was signiﬁcantly
lower in OCT-detected TCFAs than that in the non-TCFAs
(35.1±32.3HUversus62.0±33.6HU ,P<0.001).Kuboetal.
[28]assessedtherelationshipbetweenplaquecolorevaluated
by coronary angioscopy and ﬁbrous cap thickness estimated
by OCT in vivo. As a result, there was a signiﬁcant negative
correlation between yellow color intensity and ﬁbrous cap
thickness (P<0.001). Furthermore, 80% of intensive yellow
plaques were OCT-detected TCFAs with a cap thickness
of <65μm. Sawada et al. [29] compared the feasibility for
detecting TCFA between OCT and virtual histology IVUS.
Although the positive ratio of virtual histology IVUS for
detecting TCFA was 45.9%, that of OCT was 77.8%. On top
of its reliability as a tool to measure the ﬁbrous-cap thickness
in vivo, a recent OCT study conducted by Takarada et al.
[30, 31] demonstrated that the lipid-lowering therapy with
statin for 9 months signiﬁcantly increased the ﬁbrous-cap
thickness in patients with hypercholesterolemia (151 ± 110
to 280±120μm, P<0.001). As therapies to prevent or make
regression of atherosclerosis are developed, OCT can help to
assess the treatment eﬃcacy for plaque stabilization.
Plaque neovascularization is a common feature of vul-
nerable plaque. Proliferation of microvessels is considered to
berelatedtointraplaquehemorrhageandplaquedestabiliza-
tion. The high resolution of OCT provides an opportunity to
detect plaque neovascularization in vivo (Figure 7). Kitabata
et al. [32] demonstrated increase of microvessels density in
OCT-detected TCFAs in vivo. The presence of microvessels
in the plaques was also associated with positive vessel
remodeling and elevated high-sensitive C-reactive protein
levels. The OCT evaluation of microvessels density might be
helpful to assess plaque vulnerability.
A unique aspect of OCT is its ability to visualize the
macrophages (Figure 8). Tearney et al. [33]a n dM a c N e i l l
et al. [34] descried the potential of OCT to estimate
macrophage accumulation within ﬁbrous caps. There was
a high degree of positive correlation between OCT and his-
tological measurements of ﬁbrous cap macrophage density
(r<0.84, P<0.0001).ArangeofOCTsignalstandarddevi-
ation thresholds (6.15% to 6.35%) yielded 100% sensitivity
and speciﬁcity for identifying caps containing >10% CD68
staining in their study.
5. Limitationsof OCT
The current commercially available time-domain OCT sys-
tem requires vessel occlusion by means of gentle balloon
inﬂation and vessel ﬂushing with lactated Ringers’ solution
or saline infusion at the time of image acquisition because
the near-infrared light signals are attenuated by red blood
cells. Therefore, the assessment of long coronary segment
and the observation of left main coronary artery might be
limited. Inadequate displacement of blood can be a problem
in vessels >3.5mm in diameter, where large bifurcations are
present and in the presence of competitive ﬂow from collat-
erals or bypass grafts. In addition, there is concern about
the local consequences of balloon inﬂation. To overcomeCardiology Research and Practice 5
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Figure 7: Plaque neovascularization. Microvessels within the
intima (arrows) appear as signal poor voids that are sharply
delineated. Two microvessels are located in thickened intima at 7
o’clock position. (∗ = lipid).
Figure 8: Macrophages. Macrophages (arrows) are seen as signal-
rich, distinct, or conﬂuent punctuate regions that exceed the
intensity of background speckle noise. The high contrast and
resolution of OCT enable the quantiﬁcation of macrophages within
ﬁbrous caps of atherosclerotic plaques.
this limitation, a simpliﬁed technique for coronary blood
removal, which was achieved through continuous injection
ofcontrastagentsordextranwithlactateRingers’solution, is
recommended [35, 36]. This nonocclusive technique of OCT
image acquisition is safe and useful and promises to reduce
the procedural time. A further limitation of OCT is the
relatively shallow axial penetration depth of 2mm. The OCT
signal does not reach the back wall of thick atherosclerotic
lesions. The penetration depth of OCT depends on tissue
characteristics. Lipid-rich plaque or coronary thrombus
causes OCT signal attenuation, which interrupts to observe
deep layers of coronary artery wall. OCT is not appropriate
for the quantiﬁcation of lipid-core size and the evaluation
of arterial remodeling. This drawback may aﬀect the role of
OCT for assessment of lesion instability. The current OCT
is well suited for the assessment of the plaque morphologies
within 500μm of the luminal surface.
6. FuturePerspectivesof OCT
Recently, a second-generation OCT technology, named
frequency-domain OCT, has been developed. This new
technology will solve the current time-domain OCT lim-
itations by imaging at much higher frame rates with
slightly deeper penetration depth and greater scan area
[37–39]. In combination with a short, nonocclusive ﬂush
and rapid spiral pullback, the higher frame rates gener-
ated by frequency-domain OCT enable imaging of the 3-
dimensional microstructure of longer segments of coronary
arteries [40]. In addition, frequency-domain OCT facilitates
the acquisition of spectroscopic and polarization data for
tissue characterization [41]. The development of frequency-
domain OCT would allow easy and precise identiﬁcation of
vulnerable plaque in daily clinical practice.
7. Conclusions
The high resolution of OCT provides histology-grade deﬁ-
nition of the microstructures of coronary unstable plaques
in vivo. OCT can visualize unstable lesion morphologies
in vivo which have been demonstrated by histological
examinations. Thus, OCT allows a greater understanding
of the pathophysiology of ACS and may have a potential
to propose guidance for the appropriate patient-speciﬁc
therapeutic approach. Although more clinical research with
greater number of subjects and development of the imaging
technology are required, OCT will play an important role in
the future cardiology.
Abbreviations and Acronyms
ACS: Acute coronary syndrome
AMI: Acute myocardial infarction
IVUS: Intravascular ultrasound
OCT: Optical coherence tomography
PCI: Percutaneous coronary intervention
SAP: Stable angina pectoris
TCFA: Thin cap ﬁbroatheroma
UAP: Unstable angina pectoris.
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